Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1901 1
1909 2
1910 4
1911 1
1940 1
1950 1
1952 1
1957 1
1958 2
1959 2
1960 3
1961 2
1962 5
1963 2
1964 10
1965 12
1966 4
1967 5
1968 14
1969 14
1970 7
1971 7
1972 6
1973 6
1974 12
1975 8
1976 9
1977 6
1978 11
1979 4
1980 8
1981 7
1982 12
1983 13
1984 10
1985 12
1986 16
1987 19
1988 15
1989 7
1990 9
1991 12
1992 10
1993 15
1994 15
1995 14
1996 14
1997 19
1998 16
1999 12
2000 13
2001 13
2002 21
2003 14
2004 16
2005 14
2006 22
2007 28
2008 26
2009 24
2010 25
2011 32
2012 45
2013 35
2014 38
2015 39
2016 47
2017 53
2018 56
2019 48
2020 74
2021 84
2022 52
Text availability
Article attribute
Article type
Publication date

Search Results

1,147 results
Results by year
Filters applied: . Clear all
Page 1
Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.
Davis ID, Martin AJ, Stockler MR, Begbie S, Chi KN, Chowdhury S, Coskinas X, Frydenberg M, Hague WE, Horvath LG, Joshua AM, Lawrence NJ, Marx G, McCaffrey J, McDermott R, McJannett M, North SA, Parnis F, Parulekar W, Pook DW, Reaume MN, Sandhu SK, Tan A, Tan TH, Thomson A, Tu E, Vera-Badillo F, Williams SG, Yip S, Zhang AY, Zielinski RR, Sweeney CJ; ENZAMET Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Davis ID, et al. Among authors: marx g. N Engl J Med. 2019 Jul 11;381(2):121-131. doi: 10.1056/NEJMoa1903835. Epub 2019 Jun 2. N Engl J Med. 2019. PMID: 31157964 Clinical Trial.
Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.
Zarbock A, Küllmar M, Kindgen-Milles D, Wempe C, Gerss J, Brandenburger T, Dimski T, Tyczynski B, Jahn M, Mülling N, Mehrländer M, Rosenberger P, Marx G, Simon TP, Jaschinski U, Deetjen P, Putensen C, Schewe JC, Kluge S, Jarczak D, Slowinski T, Bodenstein M, Meybohm P, Wirtz S, Moerer O, Kortgen A, Simon P, Bagshaw SM, Kellum JA, Meersch M; RICH Investigators and the Sepnet Trial Group. Zarbock A, et al. Among authors: marx g. JAMA. 2020 Oct 27;324(16):1629-1639. doi: 10.1001/jama.2020.18618. JAMA. 2020. PMID: 33095849 Free PMC article. Clinical Trial.
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.
Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, Bihorac A, Birkhahn R, Cely CM, Chawla LS, Davison DL, Feldkamp T, Forni LG, Gong MN, Gunnerson KJ, Haase M, Hackett J, Honore PM, Hoste EA, Joannes-Boyau O, Joannidis M, Kim P, Koyner JL, Laskowitz DT, Lissauer ME, Marx G, McCullough PA, Mullaney S, Ostermann M, Rimmelé T, Shapiro NI, Shaw AD, Shi J, Sprague AM, Vincent JL, Vinsonneau C, Wagner L, Walker MG, Wilkerson RG, Zacharowski K, Kellum JA. Kashani K, et al. Among authors: marx g. Crit Care. 2013 Feb 6;17(1):R25. doi: 10.1186/cc12503. Crit Care. 2013. PMID: 23388612 Free PMC article. Clinical Trial.
Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial.
Barcenas CH, Hurvitz SA, Di Palma JA, Bose R, Chien AJ, Iannotti N, Marx G, Brufsky A, Litvak A, Ibrahim E, Alvarez RH, Ruiz-Borrego M, Chan N, Manalo Y, Kellum A, Trudeau M, Thirlwell M, Garcia Saenz J, Hunt D, Bryce R, McCulloch L, Rugo HS, Tripathy D, Chan A; CONTROL Study Investigators. Barcenas CH, et al. Among authors: marx g. Ann Oncol. 2020 Sep;31(9):1223-1230. doi: 10.1016/j.annonc.2020.05.012. Epub 2020 May 25. Ann Oncol. 2020. PMID: 32464281 Free article. Clinical Trial.
Telemedizin: Chancen und Grenzen in der Intensivmedizin.
Deisz R, Rademacher S, Marx G. Deisz R, et al. Among authors: marx g. Anasthesiol Intensivmed Notfallmed Schmerzther. 2017 Feb;52(2):94-106. doi: 10.1055/s-0042-108712. Epub 2017 Feb 21. Anasthesiol Intensivmed Notfallmed Schmerzther. 2017. PMID: 28222470 Review. German.
Overall Survival of Men with Metachronous Metastatic Hormone-sensitive Prostate Cancer Treated with Enzalutamide and Androgen Deprivation Therapy.
Sweeney CJ, Martin AJ, Stockler MR, Begbie S, Chi KN, Chowdhury S, Coskinas X, Frydenberg M, Hague WE, Horvath LG, Joshua AM, Lawrence NJ, Marx GM, McCaffrey J, McDermott R, McJannett M, North SA, Parnis F, Parulekar W, Pook DW, Reaume MN, Sandhu SK, Tan A, Tan TH, Thomson A, Tu E, Vera-Badillo F, Williams SG, Yip S, Zhang AY, Zielinski RR, Davis ID; ENZAMET Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP). Sweeney CJ, et al. Among authors: marx gm. Eur Urol. 2021 Sep;80(3):275-279. doi: 10.1016/j.eururo.2021.05.016. Epub 2021 May 22. Eur Urol. 2021. PMID: 34030924
Sepsis – weiter eine große Herausforderung!
Marx G. Marx G. Anasthesiol Intensivmed Notfallmed Schmerzther. 2019 Jan;54(1):8-9. doi: 10.1055/a-0808-1194. Epub 2019 Jan 8. Anasthesiol Intensivmed Notfallmed Schmerzther. 2019. PMID: 30620951 German. No abstract available.
1,147 results